The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis
These findings offer critical insights into the current state of gastric cancer treatment in China and can inform future initiatives to improve therapeutic outcomes for patients with gastric cancer.
Authors
- Keren Jia (ORCID: https://orcid.org/0000-0001-6577-0573)
- Jiajia Yuan (ORCID: https://orcid.org/0000-0002-9614-6279)
- Jia Zhong (ORCID: https://orcid.org/0009-0007-5334-5159)
- Lei Jiang (ORCID: https://orcid.org/0000-0002-8676-8859)
- Yi Xie (ORCID: https://orcid.org/0000-0001-6884-2851)
- Yang Chen (ORCID: https://orcid.org/0000-0001-6993-4870)
- Jian Li (ORCID: https://orcid.org/0000-0002-0864-5108)
- Dan Liu (ORCID: https://orcid.org/0000-0002-8376-7287)
- Haoxin Peng (ORCID: https://orcid.org/0000-0002-3423-3748)
- Lin Shen
- Xiaotian Zhang (ORCID: https://orcid.org/0000-0003-1134-0775)
Institutions
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Mayo Clinic in Arizona (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Journal of Hematology & Oncology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1186/s13045-025-01698-y
- Citations
- 39
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 59.22
Funders
- National Natural Science Foundation of China
- Peking University
- Wu Jieping Medical Foundation